Smith Hunter C bought RYTM

July 9, 2025 · Form 4 insider transaction

Smith Hunter C bought 42,120 shares of Rhythm Pharmaceuticals, Inc. at $6.88 per share, a transaction worth $289.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.